CLSN
Celsion Corp
Halal Rating :
Last Price
$0.90
Last updated:
Market Cap
-
7D Change
-1.43%
1 Year Change
70.38%
Company Overview
Exchange
Next Earnings Date
Celsion Corporation is a clinical-stage biotechnology company focused on developing cancer treatments through innovative therapies. Their primary focus is on advancing DNA-based immunotherapy and targeted chemotherapy treatments using their proprietary delivery platforms. The company's lead product candidate is GEN-1, an IL-12 DNA plasmid vector formulated into nanoparticles for the treatment of ovarian cancer.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Celsion Corp's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.